--- title: "Nephros | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 6.017 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/295136807.md" datetime: "2026-08-06T20:05:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295136807.md) - [en](https://longbridge.com/en/news/295136807.md) - [zh-HK](https://longbridge.com/zh-HK/news/295136807.md) generator: "portal-rs" --- # Nephros | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 6.017 M Revenue: As of FY2026 Q2, the actual value is USD 6.017 M, beating the estimate of USD 4.994 M. EPS: As of FY2026 Q2, the actual value is USD 0.11. EBIT: As of FY2026 Q2, the actual value is USD 1.184 M. #### Second Quarter Ended June 30, 2026 vs. 2025 - **Net Revenue**: Nephros, Inc. reported record net revenue of $6 million for the second quarter of 2026, a 36% increase compared to $4.4 million in the second quarter of 2025. Core programmatic revenue grew by 27% year over year. - **Net Income**: Net income was $1.2 million for the second quarter of 2026, compared to $0.2 million in the second quarter of 2025, including a one-time tariff refund benefit of approximately $0.6 million. - **Adjusted EBITDA**: Adjusted EBITDA for the second quarter of 2026 was $1.3 million, up from $0.4 million in the second quarter of 2025. - **Cost of Goods Sold**: Cost of goods sold increased by 23% to $2.0 million in the second quarter of 2026, compared to $1.6 million in the same period of 2025. - **Gross Margin**: Gross margin was 67% in the second quarter of 2026, an increase from 63% in the second quarter of 2025. This 4 percentage point increase was primarily due to the recognition of a $0.6 million tariff refund, recorded as a reduction of cost of goods sold, partially offset by increased costs from the weakening U.S. dollar, higher shipping expenses, and rapid growth in lower-margin service revenue. - **Operating Expenses**: - **Selling, General and Administrative Expenses**: These expenses rose by 10% to approximately $2.4 million in the second quarter of 2026, from $2.2 million in 2025, driven by increases in headcount and sales commissions. - **Research and Development Expenses**: These expenses increased by 18% to approximately $366,000 in the second quarter of 2026, compared to $311,000 in 2025, primarily due to higher salary expense. - **Depreciation and Amortization Expenses**: These expenses were approximately $29,000 in the second quarter of 2026, down from approximately $35,000 in the second quarter of 2025. - **Operating Income**: Operating income was $1.213 million for the second quarter of 2026, compared to $0.248 million for the same period in 2025. - **Other (expense) income**: Total other expense was - $3 thousand in Q2 2026, compared to - $2 thousand in Q2 2025. - **Income (loss) before income taxes**: This figure was $1.210 million in Q2 2026, up from $0.246 million in Q2 2025. - **Income tax expense**: Income tax expense was - $13 thousand in Q2 2026, compared to - $9 thousand in Q2 2025. #### Six Months Ended June 30, 2026 vs. 2025 - **Net Revenue**: Net revenue for the six months ended June 30, 2026, was $11.2 million, an increase of 21% from $9.3 million in the same period of 2025. Core programmatic revenue grew by 25% over the prior year period, driven by strong reorders and new active sites. - **Cost of Goods Sold**: Cost of goods sold for the six months increased by 26% to $4.2 million in 2026, from $3.3 million in 2025. - **Gross Margin**: Gross margin was 63% for the six months ended June 30, 2026, a slight decrease from 64% in the same period of 2025. The decrease was primarily due to increased product costs from the weakening U.S. dollar, higher shipping expenses, and rapid revenue growth from lower-margin commercial products and services, though gross margins significantly benefited from the $0.6 million IEEPA tariff refund, recorded as a reduction of cost of goods sold. - **Operating Expenses**: - **Selling, General and Administrative Expenses**: These expenses increased by 11% to approximately $4.9 million for the six months ended June 30, 2026, compared to $4.5 million in 2025, primarily due to increased headcount and professional fees. - **Research and Development Expenses**: These expenses were $0.7 million in 2026, up from $0.6 million in 2025. - **Depreciation and Amortization Expenses**: These expenses were approximately $58,000 in 2026, down from approximately $74,000 in 2025. - **Net Income**: Net income for the six months ended June 30, 2026, was $1.3 million, compared to $0.8 million during the same period in 2025, driven by improved sales and the $0.6 million tariff refund. - **Adjusted EBITDA**: Adjusted EBITDA for the six months ended June 30, 2026, was approximately $1.5 million, compared with approximately $1 million in the same period of 2025. #### Balance Sheet and Cash Flow - **Cash and Cash Equivalents**: As of June 30, 2026, Nephros, Inc. had cash and cash equivalents of approximately $4.7 million, a decrease from $5.4 million as of December 31, 2025. - **Debt Status**: The company remains debt-free as of June 30, 2026. #### Outlook / Guidance Nephros, Inc. believes it is well-positioned for continued sustainable growth and increasing shareholder value. This position is supported by a growing recurring revenue base, expanding commercial opportunities, differentiated technology, and an increasingly comprehensive service platform. The company remains confident in its investments made over the past several years despite the broader economic environment. ### Related Stocks - [NEPH.US](https://longbridge.com/en/quote/NEPH.US.md) ## Related News & Research - [Algorhythm Holdings Reports Second Quarter 2026 Financial Results](https://longbridge.com/en/news/296124832.md) - [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md) - [REG - UIL Limited UIL Finance Ltd - Purchase of 2026 ZDP Shares](https://longbridge.com/en/news/296518280.md) - [Corning sets Q3 2026 dividend at R$ 0.25 per unit](https://longbridge.com/en/news/296635714.md) - [Apple declares Q3 2026 distribution of R$ 0.05 per unit, payable Aug. 19](https://longbridge.com/en/news/296137926.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**